5 Cheap Rising Stocks to Buy
In March, J.P. Morgan upgraded KB Home (NYSE:KBH) to Neutral from Underweight after the company’s strong Q1 report and solid 2023 guidance.
Posts Tagged ‘NASDAQ:SNY’
5 Best Covid Treatment Stocks to Buy Today
39 of the 943 hedge funds part of Insider Monkey's database had held a stake in the company during last year's fourth quarter.
11 Most Promising Cancer Stocks According to Analysts
In this article, we discuss 11 most promising cancer stocks according to analysts.
12 Most Profitable Pharmaceutical Stocks Now
The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living.
25 Most Profitable NASDAQ Stocks Today
In this article, we will look at the 25 most profitable NASDAQ stocks today.
Sanofi (NASDAQ:SNY) Q4 2022 Earnings Call Transcript
Eva Schaefer-Jansen: find the slides to this earnings call on the Investors page of our website at sanofi.com.
Should You Hold Sanofi (SNY)?
ClearBridge Investments, an investment management company, released its “ClearBridge International Value Strategy” third quarter 2022 investor letter.
5 Biggest European Pharmaceutical Companies
MERCK Kommanditgesellschaft auf Aktien (XETRA:MRK.DE) is a German company that develops drugs for cancer, neurology, cardiology, and other diseases.
5 Best Foreign Stocks With Dividends
In this article, we will discuss 5 best foreign stocks with dividends.
5 Best European Dividend Stocks to Buy Now
In this article, we discuss 5 best European dividend stocks to buy now.
10 Best European Dividend Stocks to Buy Now
In this article, we will discuss the 10 best European dividend stocks to buy now.
10 Best COVID Stocks To Buy Now
In 2020, the COVID-19 pandemic was the primary driver of global uncertainty, making headlines around the world.
25 Biggest Pharmaceutical Companies in the World A Year Ago
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
5 Stocks to Buy According to Stephen DuBois’ Camber Capital Management
In this article, we discuss 5 stocks to buy according to Stephen DuBois' Camber Capital Management.
Billionaire Ray Dalio is Shorting These 10 European Stocks
In this article, we discuss the 10 European stocks billionaire Ray Dalio is shorting.
Investors are Watching These 10 Biotech Stocks
In this article, we discuss the 10 biotech stocks that investors are watching.
Hedge Fund and Insider Trading News: Ken Griffin, Cliff Asness, Ray Dalio, Sanjay Shah, Brookfield Asset Management, Savara Inc (SVRA), Day One Biopharmaceuticals, Inc. (DAWN), and More
Ken Griffin is moving Citadel’s headquarters to Miami, leaving its current home of Chicago after the billionaire decried the city’s crime rate and voiced frustrations with...
15 Best Drug Stocks To Buy Now
The pharmaceutical industry is thriving globally, and it was given a healthy boost by the COVID-19 vaccine rollouts around the world.
10 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.
10 Biotech Stocks to Buy According to Billionaire Ken Fisher
In this article, we discuss the 10 biotech stocks to buy according to billionaire Ken Fisher.
10 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at 10 biotech and pharma stocks to buy according to billionaire Steve Cohen.
11 Best Covid Vaccine and Pill Stocks To Invest In
In this article, we discuss the 11 best Covid vaccine and pill stocks to invest in.
10 High-Yield Dividend Stocks to Buy According to Ken Fisher
In this article, we discuss the 10 high-yield dividend stocks to buy according to Ken Fisher.
15 Best Pharmaceutical Stocks to Invest In
In this article, we discuss the 15 best pharmaceutical stocks to invest in.
15 Best Medical Stocks to Invest In
In this article we will take a look at the 15 best medical stocks to invest in.
Warren Buffett’s 5 Worst Investments of All Time
In this article we discuss Warren Buffett's 5 worst investments of all time.
Top 10 Vaccine Companies in the World
In this article, we take a look at the top 10 vaccine companies in the world.
Sanofi (SNY) A Top Detractor in Artisan Value’s Portfolio
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Value Fund’ fourth quarter 2020 investor letter – a copy of which...
Hedge Fund and Insider Trading News: Paul Tudor Jones, Ray Dalio, David Einhorn, Alan Howard, Bill Ackman, NVIDIA Corporation (NVDA), Kraft Heinz Co (KHC), and More
It’s been a tough year for David Einhorn, one-time enfant terrible of hedge funds.
Is Sanofi (SNY) a Smart Long-term Buy?
Generation PMCA recently released its Q3 2020 Investor Letter. The fund is managed by co-founders Randall Abramson and Herb Abramson.
Hedge Funds Are Coming Back To Sanofi (SNY)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Never Been Less Bullish On Sanofi (SNY)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Should You Be Tempted To ‘Sell’ Sanofi (SNY) Stock
Diamond Hill Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Hedge Fund Consensus Stocks vs. Sanofi (SNY) In 2019
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Not Much Chemistry Between Sanofi (SNY) and Hedge Funds
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Are In Wait And See Mode With Sanofi (SNY)
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Here’s What Hedge Funds Think About Sanofi (SNY)
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Dan Loeb, Elliott Management, Kirkland’s, Inc. (KIRK), Sharps Compliance Corp. (SMED), and More
President Donald Trump said he hasn’t decided who will replace Sarah Huckabee Sanders as White House press secretary but that it won’t be his former communications director...
Were Hedge Funds Right About Selling Sanofi (SNY)?
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
